“…Because of the long duration of plasma concentrations, cefovecin is an appealing therapeutic option for exotic species housed in zoo collections, with the potential to minimize repeated handling, injection, and anesthetic events, and circumvent non‐compliance in food‐averse patients (Bertelsen et al, 2010). However, its properties and efficacy can vary widely with taxon, necessitating rigorous evaluation in the target species to demonstrate its effectiveness and justify its use (García‐Párraga et al, 2016; Lee et al, 2016; Nardini et al, 2014; Steeil et al, 2014; Sypniewski et al, 2017; Thuesen et al, 2009). Cefovecin use has been reported in a variety of non‐domestic felids—including caracals, tigers, lions, an ocelot, lynx, and bobcats—with minimal to no adverse effects reported (Bertelsen et al, 2010; DeFrancisco & Stern, 2013; Devesa‐Garcia et al, 2016; Marti et al, 2019; Mejia‐Fava et al, 2015; Sadler et al, 2016; Schrader et al, 2012; Silva et al, 2013; Steeil et al, 2012).…”